Phylinda L. S. Chan

Paracetamol plasma and cerebrospinal fluid pharmacokinetics in children

Brian J. Anderson, Nicholas H. G. Holford, Gerald Woollard et al. · British Journal of Clinical Pharmacology · 1998 · 105 citations · Full text

Disease Progression and Pharmacodynamics in Parkinson Disease – Evidence for Functional Protection with Levodopa and Other Treatments

Nicholas H. G. Holford, Phylinda L. S. Chan, John G. Nutt et al. · Journal of Pharmacokinetics and Pharmacodynamics · 2006 · 90 citations

Neurodegenerative Diseases, Disease Progression, Medicine +12

The use of the SAEM algorithm in MONOLIX software for estimation of population pharmacokinetic-pharmacodynamic-viral dynamics parameters of maraviroc in asymptomatic HIV subjects

Phylinda L. S. Chan, Philippe Jacqmin, Marc Lavielle et al. · Journal of Pharmacokinetics and Pharmacodynamics · 2010 · 86 citations · Full text

Viral Load Data, Maraviroc Monotherapy, Neurovirology +15

Levodopa Slows Progression of Parkinson’s Disease. External Validation by Clinical Trial Simulation

Phylinda L. S. Chan, John G. Nutt, Nicholas H. G. Holford · Pharmaceutical Research · 2007 · 61 citations

Neurodegenerative Diseases, External Validation, Levodopa Slows Progression +11

Pharmacokinetic and Pharmacodynamic Changes During the First Four Years of Levodopa Treatment in Parkinson’s Disease

Phylinda L. S. Chan, John G. Nutt, Nicholas H. G. Holford · Journal of Pharmacokinetics and Pharmacodynamics · 2005 · 30 citations

Neurodegenerative Diseases, First Four, Pharmacodynamic Changes +11